Wire · opportunities
ARPA-H funds $62.7M in AI agents for heart failure care
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 September 2026 · Fusion42 review
The U.S. Advanced Research Projects Agency for Health (ARPA-H) has committed $62.7 million over four years to its ADVOCATE program to develop autonomous AI agents for heart failure care, including drug prescribing. This initiative runs alongside efforts by the FDA and Medicare to create new payment and regulatory pathways enabling clinical AI deployment.
This Wire brief sits within Fusion42's coverage of Digital Health, and 2 sources have reported it between 11 Sep 2026 and 15 Sep 2026.
◆ ◆ The Wire takeaway
You must prepare your clinical AI product for new FDA and Medicare frameworks that will soon allow AI agents to prescribe and manage care directly. This regulatory push opens rapid market access but demands compliance readiness within two years or risk being sidelined.
◆ Coverage
2 sources · first reported 11 Sep 2026 · latest 15 Sep 2026
◆ Related on Wire
◆ Topics